原位凝胶在肿瘤治疗中的应用进展

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

原位凝胶在肿瘤治疗中的应用进展

樊莉, 何文婷, 高申

文章导航 > 药学实践与服务 > 2013 > 31(4): 251-253,285

樊莉, 何文婷, 高申. 原位凝胶在肿瘤治疗中的应用进展[J]. 药学实践与服务, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

引用本文:

樊莉, 何文婷, 高申. 原位凝胶在肿瘤治疗中的应用进展[J]. 药学实践与服务, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

FAN Li, HE Wen-ting, GAO Shen. Application of in situ gel in cancer therapy[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

Citation:

FAN Li, HE Wen-ting, GAO Shen. Application of in situ gel in cancer therapy[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

原位凝胶在肿瘤治疗中的应用进展

doi: 10.3969/j.issn.1006-0111.2013.04.003

1.
第二军医大学药学院, 上海 200433
2.
福建中医药大学药学系, 福建福州 350108
3.
第二军医大学附属长海医院药学部, 上海 200433

Application of in situ gel in cancer therapy

1.
Department of Pharmaceutical Science, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2.
Department of Pharmacy, Fujian Traditional Chinese Medicine University, Fuzhou 350108, China
3.
Department of Pharmacy, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

摘要: 原位凝胶因其局部药物浓度高、给药方便等特性在肿瘤治疗中显示出特殊优势,具有较好的临床应用前景。本文对近5年来原位凝胶在乳腺癌、肝癌、胰腺癌等不同种类的肿瘤治疗中的应用进行了综述,对其发展前景进行了展望。
- 原位凝胶 /
- 肿瘤治疗
Abstract: In situ gel has shown special advantages in cancer therapy due to high local drug concentration and convenient administration, which made it be promising in future clinical application. In this paper, the application of in situ gel in different tumor types of breast cancer, liver cancer, pancreatic cancer therapy were reviewed for the past 5 years, and the development of in situ gel were prospected.
- in situ gel /
- cancer therapy

[1]	Maugham SM, Hunter AC, Murray JC.Nanomedicine:current status and future prospects[J].FASEBJ.2005,19:311.
[2]	Kempf RA, Mitchell MS.Effects of chemotherapeutic agents on the immune response[J].Cancer Invest,1984,2:459.
[3]	Qien F,Stowe N,Liu EH,et al. Quantification of in vivo doxombicin transport from PLGA millirods in thermoablated rat livers[J].Control Release.2003, 91(1-2):157.
[4]	Ahmed M, Liu Z, Lukyanov AN, et al. Combination radiofrequency ablation with intratumoral liposome doxorubicin:effect on drug accumulation and coagulation in multiple tissues and tumor types in animals[J].Radiology, 2005, 235(2):469.
[5]	仇海镇,李娟.原位凝胶的研究进展及其在药剂学中的应用[J].医学信息,2010,4(23):4.
[6]	Gariepy ER, Shive M, Bichara A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel[J].Eur J Pharm Biopharm,2004, 57:53.
[7]	Lei N, Gong CY, Qian ZY et al. Therapeutic application of injectable thermosensitive hydrogel in preventing local breast cancer recurrence and improving incision wound healing in a mouse model[J].Nanoscale,2012,4:5686.
[8]	Guo DD, Hong SH, Jiang HL, et al. Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer[J].Biomaterials, 2012,33:2272.
[9]	谢峰,杨甲梅.原发性肝癌间质化疗的实验及临床研究进展[J].中华普通外科杂志.2010,11,(25):943.
[10]	Leung TW, Yu S, Johnson PJ, et al. PhaseⅡstudy of the efficacy and safety of cisplatin-epinephrine injectable gel administered to patients with unresectable hepatocellular carcinoma[J].Clinoncol,2003,21(4):652.
[11]	Mok TS,Kanekal S, Lin XR, Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma[J].Cancer, 2001,91(12);2369.
[12]	Harbord M, Dawes RF, Barr H, et al. Palliation of patients with dysphagia due to advanced esophageal cancer by endoscopic injection of cisplatin/epinephrine injectable gel[J]. Gastrointest Endosc.2002,56(5):644.
[13]	药晋鹏,戴立里,李娟,等.载阿霉素的液-固相变型原位凝胶注射治疗兔VX2肝癌HIFU消融后残癌[J]. 中国介入影像与治疗学,2012,9(11):34.
[14]	Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J].CA Cancer J Clin, 2005, 55(2):74.
[15]	Strocchi P, Dozza B, Pecorella I, et al. Lesions caused by ricin applied to rabbit eyes[J].Invest Ophthalmol Vis Sci,2005,46:1113.
[16]	Chen ZK,Lin LW,Weng XH,et al. Interstitial chemotherapy with ricin-loaded thermosensitive hydrogel in pancreatic cancer xenograft[J].Hepatobiliary Pancreat Dis Int, 2009,8(4):418.
[17]	Gao Y, Ren FZ, Ding BY,et al. A thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of docetaxel[J]. J Drug Targeting, 2010, 1:12.
[18]	Maran A, Dadsetan M, Buenz M, et al. Hydrogel-PLGA delivery system prolongs 2-methoxyestradiol-mediated anti-tumor effects in osteosarcoma cells[J]. J Biomed Mater Res,2013,1:6.
[19]	Lee H, Mok H, Lee S, et al. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels[J]. Control Rel, 2001, 119(2):245.
[20]	Seruga B, Sterling L,Wang L, et al. Reporting of serious adverse drug reactions of targeted anticancer agents in pivotal phase Ⅲ clinical trials[J]. J Clin Oncol, 2011,9(2):174.
[21]	朱卫,徐元龙,李学明,智能纳米水凝胶及其药剂学研究新进展[J]. 中国新药杂志,2011,20(6):518.

[1]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 1-8. doi: 10.12206/j.issn.2097-2024.202401073
[2]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[3]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[4]	丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉. 消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031
[5]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035
[6]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[7]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[8]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[9]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[10]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[11]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[12]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 1-5. doi: 10.12206/j.issn.2097-2024.202405059
[13]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034

WeChat

点击查看大图

计量

文章访问数: 2406
HTML全文浏览量: 235
PDF下载量: 242
被引次数: 0

原位凝胶在肿瘤治疗中的应用进展

doi: 10.3969/j.issn.1006-0111.2013.04.003

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学系, 福建福州 350108

3. 第二军医大学附属长海医院药学部, 上海 200433

收稿日期: 2013-05-06
修回日期: 2013-05-19

关键词:

摘要: 原位凝胶因其局部药物浓度高、给药方便等特性在肿瘤治疗中显示出特殊优势,具有较好的临床应用前景。本文对近5年来原位凝胶在乳腺癌、肝癌、胰腺癌等不同种类的肿瘤治疗中的应用进行了综述,对其发展前景进行了展望。

English Abstract

樊莉, 何文婷, 高申. 原位凝胶在肿瘤治疗中的应用进展[J]. 药学实践与服务, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

引用本文:

樊莉, 何文婷, 高申. 原位凝胶在肿瘤治疗中的应用进展[J]. 药学实践与服务, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

FAN Li, HE Wen-ting, GAO Shen. Application of in situ gel in cancer therapy[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

Citation:

FAN Li, HE Wen-ting, GAO Shen. Application of in situ gel in cancer therapy[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(4): 251-253,285. doi: 10.3969/j.issn.1006-0111.2013.04.003

全文HTML

参考文献 (21)

/

下载: 全尺寸图片幻灯片

分享

用微信扫码二维码

分享至好友和朋友圈

返回

版权所有：《药学实践与服务》编辑委员会

主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

网站备案号沪ICP备05003363号-1

本系统由北京仁和汇智信息技术有限公司开发